SERVA ENERGY, INC.

TEMPE, AZ · Founded 2017 · CIK 0001779623 · Biotech

GMP-grade terbium-161 radioisotope for targeted radiotherapeutic drugs

servaenergy.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$7.1M
13 Form D · May 2026
5 months since last filing
Contracts
—
No federal contracts on record
Patents
1
0 granted · 1 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$5,000,000
Private capital raisedForm D · SEC$100,000
Private capital raisedForm D · SEC$125,760
Private capital raisedForm D · SEC$500,000
Private capital raisedForm D · SEC$3,000,000
Private capital raisedForm D · SEC$550,000
Private capital raisedForm D · SEC$25,000
Private capital raisedForm D · SEC$700,000
Private capital raisedForm D · SEC$130,000
Private capital raisedForm D · SEC$2,025,000
Private capital raisedForm D · SEC$60,000
Private capital raisedForm D · SEC$371,030
Private capital raisedForm D · SEC$2,500,000
Form D · SEC

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
3368COLLABORATIONS PHARMACEUTICALS INC——
3369Centivax Inc——
3370SPERAGEN, INC.——
3371SERVA ENERGY, INC.—$7.1M
3372SwanBio Therapeutics——
3373Akston Biosciences Corp—$17M
3374Aqualung Therapeutics Corp.—$3.1M

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 8 related persons
  • Neil AlfordDirector
  • Terry AlfordDirector
  • Greg AndersonExecutive Officer
  • Ian HorvathDirector · Executive Officer
  • Ed MurrerDirector
  • Neil O'LearyDirector
  • Charles RunyanDirector
  • Tim VatuoneExecutive Officer

Patents

USPTO · 0 granted of 1
  • Techniques For Producing ACTINIUM-225 And Related Systems And Methodsapplication

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.